| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 79,436 | 73,207 | 49,793 | 42,392 | | Cost of Revenue | 47,156 | 56,006 | 30,544 | 34,724 | | | Gross Profit | 32,280 | 17,201 | 19,249 | 7,668 | | | Operating Expenses | | Research Development | 10,785 |
-
|
-
| (17,222) | | Selling General and Administrative | 8,733 | 3,959 | 9,074 | 8,838 | | Non Recurring |
-
|
-
|
-
| 16,950 | | Others | 27,027 | 21,160 | 9,279 | 8,739 | | | | Total Operating Expenses |
-
|
-
|
-
| 17,305 | | | | Operating Income or Loss | (14,265) | (7,918) | 896 | (9,637) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (40,368) | 21,018 | 7,344 | 510 | | Earnings Before Interest And Taxes | (54,633) | 13,100 | 8,240 | (9,127) | | Interest Expense | 6,089 | 5,193 | 765 | 1,448 | | Income Before Tax | (60,722) | 7,907 | 7,475 | (10,575) | | Income Tax Expense | (15,987) | (3,702) | 1,417 | (14,858) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (44,735) | 11,609 | 6,058 | 4,283 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,283) | 11,609 | 6,058 | 4,283 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,283) | $11,609 | $6,058 | $4,283 |
|
0.51% Nasdaq 
Income Statement
